John Dempster
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A multi-centre UK-based survey on angioedema secondary to acquired C1 inhibitor deficiency.
Journal: Clinical and experimental immunology
Published: July 20, 2024
Lanadelumab for the prevention of hereditary angioedema attacks: A real-world UK audit.
Journal: Allergy
Published: September 10, 2022
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.
Journal: Frontiers in immunology
Published: July 01, 2022
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK.
Journal: Clinical and experimental immunology
Published: November 05, 2021
Dynamic clamping human and rabbit atrial calcium current: narrowing ICaL window abolishes early afterdepolarizations.
Journal: The Journal of physiology
Published: February 13, 2019
Practicalities of a reduced volume formulation of a C1-INH concentrate for the treatment of hereditary angioedema: real-life experience.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: January 29, 2018
Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: August 24, 2017
Expert perspectives on hereditary angioedema: Key areas for advancements in care across the patient journey.
Journal: Allergy & rhinology (Providence, R.I.)
Published: September 24, 2016
The transition of smooth muscle cells from a contractile to a migratory, phagocytic phenotype: direct demonstration of phenotypic modulation.
Journal: The Journal of physiology
Published: April 28, 2016
Last Updated: 09/26/2026